Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
57.79 USD | -1.16% | -4.45% | +44.47% |
Financials (USD)
Sales 2024 * | 135M | Sales 2025 * | 181M | Capitalization | 2.28B |
---|---|---|---|---|---|
Net income 2024 * | -30M | Net income 2025 * | -18M | EV / Sales 2024 * | 16.1 x |
Net cash position 2024 * | 101M | Net cash position 2025 * | 107M | EV / Sales 2025 * | 12 x |
P/E ratio 2024 * |
-71.6
x | P/E ratio 2025 * |
-118
x | Employees | 374 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.84% |
Latest transcript on RxSight, Inc.
1 day | -1.16% | ||
1 week | -4.45% | ||
Current month | -0.38% | ||
1 month | -5.56% | ||
3 months | +3.89% | ||
6 months | +85.04% | ||
Current year | +44.47% |
Managers | Title | Age | Since |
---|---|---|---|
Ronald Kurtz
CEO | Chief Executive Officer | 61 | 15-05-31 |
Shelley Thunen
DFI | Director of Finance/CFO | 71 | 15-12-31 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Palmisano
BRD | Director/Board Member | 79 | 21-08-09 |
Bill Link
BRD | Director/Board Member | 78 | 16-10-31 |
Ronald Kurtz
CEO | Chief Executive Officer | 61 | 15-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 1,487 M€ | +8.07% | - | |
0.00% | 9 M€ | +9.22% | - | |
0.00% | 34 M€ | +4.01% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-03 | 58.25 | -0.38% | 59 335 |
24-05-31 | 58.47 | -1.76% | 392,195 |
24-05-30 | 59.52 | -1.39% | 273,323 |
24-05-29 | 60.36 | -0.98% | 283,888 |
24-05-28 | 60.96 | -0.31% | 248,727 |
Delayed Quote Nasdaq, June 03, 2024 at 11:55 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.47% | 2.28B | |
-6.38% | 178B | |
-0.83% | 107B | |
-2.15% | 67.04B | |
-5.92% | 47.23B | |
+11.59% | 44.62B | |
+9.25% | 42.5B | |
+14.39% | 29.99B | |
+15.97% | 25.22B | |
-6.80% | 24.14B |
- Stock Market
- Equities
- RXST Stock